Does Proactive Therapy Reduce Relapse in Atopic Dermatitis? A Systematic Review and Meta-Analysis
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by a high relapse rate. Proactive therapy, which involves intermittent application of topical anti-inflammatory agents after clinical remission, was developed to suppress subclinical inflammation and prevent relapse. Objective: This study aimed to evaluate the effectiveness and safety of proactive maintenance therapy compared with reactive therapy in preventing relapse in AD patients. Methods: A systematic review and meta-analysis were conducted following the PRISMA 2020 guidelines. A literature search was conducted on PubMed, CENTRAL, ClinicalTrials.gov, and OpenAlex. Inclusion criteria included RCTs comparing proactive therapy with reactive therapy or emollient control in patients with disease stabilization. Outcomes were analyzed using a random-effects model. Results: Eight RCTs met the inclusion criteria. Meta-analysis showed that proactive therapy was associated with a significant reduction in relapse rates (Odds Ratio = 0.31; 95% CI 0.17–0.58; p<0.001) and a prolongation of time to first relapse (Hazard Ratio = 0.16; 95% CI 0.04–0.60; p=0.007). Individual studies consistently demonstrated prolonged remission with both TCS and TCI. The safety profile demonstrated favorable outcomes with no evidence of skin atrophy with long-term use. Conclusion: Proactive therapy is an effective, evidence-based strategy for long-term AD control, significantly reducing the frequency of relapses without clear evidence of increased serious adverse events during the reported study period
Authors
- Thalia Sebastian
- Kathy
- Khairun Najda
Publication Details
- Journal
- JIKES Jurnal Ilmu Kesehatan
- Published
- 2026-11-14
- DOI
- https://doi.org/10.71456/jik.v5i1.2529
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00